Dual therapeutic utility of proteasome modulating agents for pharmaco-gene therapy of the cystic fibrosis airway

Spirovant Sciences, Inc.
3675 Market Street, Suite 900 Philadelphia, PA 19104
info@spirovant.com
(267) 244-8206